Can the Bladder Stimulation Technique Solve the Urine Collection Chaos in the Pediatric Emergency Department? A Prospective Comparison with the Traditional Bag Method. [PDF]
Children (Basel)Göktuğ A +7 more
europepmc +1 more source
Breast Sculpting: An Anatomically Based Reconstruction During 408 Breast Explantations. [PDF]
Plast Reconstr Surg Glob OpenMaciel PJ +4 more
europepmc +1 more source
The Effects of a Body Safety Training Program for Children from Low-Income Families on Children's Self-Protection Skills. [PDF]
Healthcare (Basel)Genç M, İzciler F, Aslan N.
europepmc +1 more source
A Pathology-Instructed Theranostic Platform with Mechanoadaptive and ROS-Powered Nanobreathing Functions for Precision Myocardial Repair. [PDF]
Adv Sci (Weinh)Luo Z +7 more
europepmc +1 more source
Incidental Discovery of a Fallopian Tube Mesenteric Borderline Serous Tumor During Cesarean Section: A Case Report and Literature Review. [PDF]
Am J Case RepTuo Y, Chen D, Geng Y, Liao L.
europepmc +1 more source
Utility of Infrared Thermography in Dogs with Osteoarthritis. [PDF]
Animals (Basel)Lewis MJ +6 more
europepmc +1 more source
BST-2/tetherin is overexpressed in mammary gland and tumor tissues in MMTV-induced mammary cancer [PDF]
Virology, 2013 BST-2 restricts MMTV replication, but once infection has established, MMTV modulates BST-2 levels. MMTV-directed BST-2 modulation is tissue-specific and dependent on infection and neoplastic transformation status of cells.
Chioma M Okeoma +2 more
exaly +2 more sources
Modulation of hepatitis C virus release by the interferon-induced protein BST-2/tetherin [PDF]
Virology, 2012 Hepatitis C virus is a leading cause of chronic hepatitis and liver cancer. Little information exists on the interplay between innate defense mechanisms and viral antagonists that promote viral egress. Herein, the effects of Tetherin/BST-2 on HCV release
Ran Taube, Alona Kuzmina
exaly +2 more sources
BST-2 is a potential activator of invasion and migration in tamoxifen-resistant breast cancer cells
Biochemical and Biophysical Research Communications, 2013 Bone marrow stromal cell antigen 2 (BST-2) is a type II transmembrane protein that is known to be a therapeutic target in several types of cancer. However, despite its clinical importance, the roles of BST-2 expression have remained elusive.
Sang-Kyu Ye, Byung-Hak Kim, Jin-Ku Lee
exaly +2 more sources